| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5mg | ¥ 1280.00 | 100 | |
| 10mg | ¥ 2050.00 | 100 | |
| 50mg | ¥ 4850.00 | 100 | |
| 100mg | ¥ 7760.00 | 100 | |
| 200mg | ¥ 12300.00 | 100 |
| 产品名 | STM2457 |
| CAS号 | 2499663-01-1 |
| 目录号 | D809870 |
| 化学式 | C₂₅H₂₈N₆O₂ |
| 分子量 | 444.53 |
| 溶解度 | DMSO : 270 mg/mL |
| 靶点 | A first-in-class, highly potent, selective and orally active METTL3 inhibitor |
| 储存条件 | Store at -20°C |
| 用途 | 仅供科学研究使用!不能用于人体及动物治疗 |
| 纯度 | >99% |
靶点及简介 :
A first-in-class, highly potent, selective and orally active METTL3 inhibitor
一种有效的METTL3/METTL14催化活性抑制剂,IC50为16.9nm,Kd为1.4nm。STM2457对METTL3具有高度特异性,具有显著的抗白血病作用。
| 分子量 | 444.53 | ||
|---|---|---|---|
| 化学式 | C25H28N6O2 | ||
| CAS号 | 2499663-01-1 | ||
| 储存条件 | 3年 | -20°C | 粉状 |
| 1年 | -80°C | 溶于溶剂 | |
体外研究:
STM2457 has a highly efficient and selective catalytic inhibition on RNA methyltransferase METTL3, causing gene-expression defects consistent with an effect on the mRNA translational efficiency of m6A substrates.[1]
体内研究
STM2457 prevents acute myeloid leukaemia (AML) expansion and reduces the number of key leukaemia stem cells in vivo.[1]
验证:
参考文献:
| DMSO | 89 mg/mL (200.21 mM) |
| Ethanol | 89 mg/mL (200.21 mM) |
| Water | Insoluble |
| 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.2496 mL | 11.2478 mL | 22.4957 mL |
| 5 mM | 0.4499 mL | 2.2496 mL | 4.4991 mL |
| 10 mM | 0.2250 mL | 1.1248 mL | 2.2496 mL |
| 50 mM | 0.0450 mL | 0.2250 mL | 0.4499 mL |